EVH Insider Trading Activity and SEC Form 4 Filings
EVH insider trading summary
Over the past 12 months, insiders at Evolent Health, Inc. (EVH) reported 1 open-market purchase worth $38K by 1 insider and 1 sale worth $329K by 1 insider on SEC Form 4. Net insider selling was $291K.
Latest EVH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Daniel Joseph McCarthy | President | Sell | $329K (65,892 @ $5.00) |
| Nov 18, 2025 | Brendan B Springstubb | Director | Buy | $38K (10,000 @ $3.82) |
| Mar 7, 2025 | Kim Keck | Director | Buy | $99K (10,540 @ $9.44) |
| Mar 7, 2025 | Richard M Jelinek | Director | Buy | $136K (15,000 @ $9.09) |
| Mar 7, 2025 | Brendan B Springstubb | Director | Buy | $139K (15,000 @ $9.27) |
| Mar 7, 2025 | Richard M Jelinek | Director | Buy | $137K (15,000 @ $9.16) |
| Mar 6, 2025 | Russell Monroe Glass | Director | Buy | $50K (5,400 @ $9.27) |
| Mar 6, 2025 | Diane Holder | Director | Buy | $26K (2,735 @ $9.33) |
| Mar 6, 2025 | Daniel Joseph McCarthy | President | Buy | $99K (11,040 @ $9.01) |
| Mar 6, 2025 | Peter J Grua | Director | Buy | $99K (11,040 @ $9.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.